Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
SLAM DRILLS MORE COPPER MINERALIZATION AT GOODWIN (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Satellos Bioscience Inc Com V.ICO


Primary Symbol: ICOTF

Healthcare Biotechnology
iCo Therapeutics Inc is a Canada based biotechnology company. It is involved in the Research and development of ophthalmic indications. The company identifies, develops, and commercialize drug candidates with clinical history, and re-doses, reformulates and develops these drug candidates to treat sight and life-threatening diseases. Its in-licensed assets are iCo-008 and the Oral AmpB Delivery System. iCo-008 is a human monoclonal antibody targeting eotaxin-1 that acts as a messenger between...


GREY:ICOTF - Post by User

Satellos Bioscience Inc Com > Bertilimumab coming to market Q4 2018
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1)
•••
Comment by Hampoooon Jul 22, 2018 2:05am
157 Views
Post# 28349697

RE:RE:Bertilimumab coming to market Q4 2018

RE:RE:Bertilimumab coming to market Q4 2018Volume tells the full story i remember my first stock in the stock market its was called SRZ sunrise Senior Living i bought it at 1.38 it eventually got bought out over 14 dollar's and i was proud of my achievement and decided to stick with high volume stocks that had potential and not just one day high volume multiday high volume, something like ICO is one of the best example of this. Moral of the story is stick with something you believe in it will eventually it will pay off
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities